EMR vs XERS · P/E 34, rev $4.86B vs rev $175.2M
Emerson Electric Company (EMR) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
EMR currently screens at market cap $83.45B and trailing P/E 34.5. XERS currently screens at market cap $760.7M.
Not investment advice. Open the EMR and XERS stock pages for the full models.
Not investment advice.